Novartis Pharmaceuticals Director of Business Development Salaries in New York
The average Novartis Pharmaceuticals Director of Business Development in New York earns $180,000 annually, which includes a base salary of $175,000 with a $5,000 bonus. This total compensation is $13,734 more than the US average for a Director of Business Development.
In New York, The Business Development Department at Novartis Pharmaceuticals earns $5,471 more on average than the HR Department. Comparably data has a total of 1 salary record from Novartis Pharmaceuticals Directors of Business Development.
Last updated 2 years ago.
- $175,000
- avg. base
- $5,000
- avg. bonus
Director of Business Development Salaries at Novartis Pharmaceuticals
In New York, Directors of Business Development earn $18,388 more than Business Development Managers.
Compensation at Novartis Pharmaceuticals by Department
In New York, The Business Development Department averages $5,471 more than the HR Department, and $1,711 less than the Communications Department
Recent Director of Business Development Salaries at Novartis Pharmaceuticals
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Novartis Pharmaceuticals reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Novartis Pharmaceuticals reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Novartis Pharmaceuticals Rate Their Compensation
The majority of Directors of Business Development at Novartis Pharmaceuticals believe they're compensated fairly. 100% of Directors of Business Development at Novartis Pharmaceuticals say they receive annual bonuses, and the vast majority (79%) are satisfied with their benefits. See more compensation ratings at Novartis Pharmaceuticals
